Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 50,157 | 33,879 | 32,727 | 31,270 | 35,709 |
| Cost of Goods | 1,583 | N/A | 129 | N/A | 2,891 |
| Gross Profit | 48,574 | 33,879 | 32,598 | 31,270 | 32,818 |
| Operating Expenses | 29,095 | 55,079 | 61,905 | 41,977 | 24,871 |
| Operating Income | 20,062 | -21,200 | -29,178 | -10,707 | 8,838 |
| Other Income | 124 | 145 | 561 | 461 | 431 |
| Pre-tax Income | 20,186 | -21,055 | -28,617 | -10,246 | 9,269 |
| Income Tax | N/A | N/A | N/A | -444 | 2,077 |
| Net Income Continuous | 20,186 | -21,055 | -28,617 | -9,802 | 7,192 |
| Net Income | $20,186 | $-21,055 | $-28,617 | $-9,802 | $7,192 |
| EPS Basic Total Ops | 0.58 | -0.69 | -1.01 | -0.35 | 0.26 |
| EPS Basic Continuous Ops | 0.58 | -0.69 | -1.01 | -0.35 | 0.26 |
| EPS Diluted Total Ops | 0.55 | -0.69 | -1.01 | -0.35 | 0.25 |
| EPS Diluted Continuous Ops | 0.55 | -0.69 | -1.01 | -0.35 | 0.25 |
| EBITDA(a) | $23,020 | $-19,118 | $-26,490 | $-7,843 | $10,669 |